Skip to main content
SpringerLink
Log in

Distinct demographic factors influence the acceptance of vaccination against HPV

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

An Erratum to this article was published on 29 January 2015

Abstract

Purpose

To investigate the possible effect of demographic factors on HPV vaccination acceptance in Greece.

Methods

Analysis was performed on data from the “LYSISTRATA” project, a prospective, cross-sectional study, focusing on questions regarding the acceptance of HPV vaccination among Greek women for themselves, and their 13-year-old daughter or son. In total, 5,379 women participated in the study, between 2005 and 2011.

Results

Women born and raised in Greece were more likely to accept HPV vaccination for themselves (aOR = 4.1, 95 % CI 2.9–5.8), their daughter (aOR = 3.3, 95 % CI 2.3–4.7) and son (aOR = 3.3, 95 % CI 2.3–4.8), compared with immigrants. Similarly, women who had a Papanicolaou’s test were more likely to accept vaccination for themselves (aOR = 1.8, 95 % CI 1.4–2.3), their daughter (aOR = 1.5, 95 % CI 1.2–1.9) and son (aOR = 1.4, 95 % CI 1.1–1.7) than those never tested. Smokers were less likely to accept HPV vaccination for themselves (aOR = 0.8, 95 % CI 0.6–0.9); however, such an association was not documented concerning their children. Educational level had a rather inconsistent impact on HPV vaccination acceptance. The effect of womens’ age, monthly income, residence, profession and marital status on HPV vaccination acceptance for themselves was different than that for their daughters, and even more for their sons.

Conclusions

There are distinct demographic factors that influence HPV vaccination acceptance. Women’s perception that male vaccination is not as necessary may lead to lower acceptance of HPV vaccination for young boys and men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. zur Hausen H (2009) Papillomaviruses in the causation of human cancers—a brief historical account. Virology 384(2):260–265. doi:10.1016/j.virol.2008.11.046

    Article  CAS  PubMed  Google Scholar 

  2. Dürst M, Gissmann L, Ikenberg H, zur Hausen H (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80(12):3812–3815

    Article  PubMed Central  PubMed  Google Scholar 

  3. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H (1984) A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3(5):1151–1157

    PubMed Central  CAS  PubMed  Google Scholar 

  4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12:AID-PATH431>3.0.CO;2-F

    Article  CAS  PubMed  Google Scholar 

  5. zur Hausen H (1996) Papillomavirus infections–a major cause of human cancers. Biochim Biophys Acta 1288(2):F55–F78

    PubMed  Google Scholar 

  6. Lajer CB, von Buchwald C (2010) The role of human papillomavirus in head and neck cancer. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 118(6–7):510–519. doi:10.1111/j.1600-0463.2010.02624.x

    Article  CAS  PubMed  Google Scholar 

  7. Poljak M (2012) Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges. Clin Microbiol Infect 18(Suppl 5):64–69. doi:10.1111/j.1469-0691.2012.03946.x

    Article  PubMed  Google Scholar 

  8. Schiller JT, Castellsagué X, Garland SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123–F138. doi:10.1016/j.vaccine.2012.04.108

    Article  CAS  PubMed  Google Scholar 

  9. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.3322/caac.20107

    Article  PubMed  Google Scholar 

  10. Muñoz N, Kjaer SK, Sigurdsson K, Iversen O-E, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson S-E, Tang GWK, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KED, Sings HL, James MK, Hesley TM, Barr E, Haupt RM (2010) Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 102(5):325–339. doi:10.1093/jnci/djp534

    Article  PubMed  Google Scholar 

  11. Agorastos T, Chatzigeorgiou K, Brotherton JML, Garland SM (2009) Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far. Vaccine 27(52):7270–7281. doi:10.1016/j.vaccine.2009.09.097

    Article  CAS  PubMed  Google Scholar 

  12. Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T, Group LS (2012) Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine. Arch Gynecol Obstet 285(6):1719–1724. doi:10.1007/s00404-011-2208-z

    Article  PubMed  Google Scholar 

  13. Chatzistamatiou K, Sotiriadis A, Agorastos T (2013) Letter to the editor referring to the manuscript entitled: “Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine” reported by Sotiriadis et al. (Arch Gynecol Obstet. 2012 Jun;285(6):1719–24). Arch Gynecol Obstet. doi:10.1007/s00404-013-3010-x

    PubMed  Google Scholar 

  14. Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, Lampropoulos AF, group Ls, (2014) Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study. Eur J Cancer Prev Off J Eur Cancer Prev Organ (ECP). doi:10.1097/CEJ.0000000000000060

    Google Scholar 

  15. Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, Nicula F, Vass L, Valerianova Z, Voti L, Sauvaget C, Ronco G (2009) Cervical cancer screening policies and coverage in Europe. Eur J Cancer 45(15):2649–2658. doi:10.1016/j.ejca.2009.07.020

    Article  PubMed  Google Scholar 

  16. Kroupis C, Thomopoulou G, Papathomas TG, Vourlidis N, Lazaris AC (2007) Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiol Infect 135(6):943–950. doi:10.1017/S095026880700876X

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Rashid RM, Dahlui M, Mohamed M, Gertig D (2013) Adapting the Australian system: is an organized screening program feasible in Malaysia?–an overview of cervical cancer screening in both countries. Asian Pac J Cancer Prev APJCP 14(3):2141–2146

    Article  Google Scholar 

  18. Donadiki EM, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, Velonakis EG (2012) Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake. Vaccine 30(49):6967–6970. doi:10.1016/j.vaccine.2012.09.028

    Article  PubMed  Google Scholar 

  19. Hopkins TG, Wood N (2013) Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine 31(13):1673–1679. doi:10.1016/j.vaccine.2013.01.028

    Article  PubMed  Google Scholar 

  20. Dursun P, Altuntas B, Kuscu E, Ayhan A (2009) Women’s knowledge about human papillomavirus and their acceptance of HPV vaccine. Aus N Z J Obstet Gynaecol 49(2):202–206. doi:10.1111/j.1479-828X.2009.00947.x

    Article  Google Scholar 

  21. Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL, Ehlen TG, Dobson SR, Money DM, Patrick DM (2007) Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ 177(12):1506–1512. doi:10.1503/cmaj.071022

    Article  PubMed Central  PubMed  Google Scholar 

  22. Charakorn C, Rattanasiri S, Lertkhachonsuk A-a, Thanapprapasr D, Chittithaworn S, Wilailak S (2011) Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women. Asia Pac J Clin Oncol 7(2):160–167. doi:10.1111/j.1743-7563.2011.01392.x

    Article  PubMed  Google Scholar 

  23. Brabin L, Roberts SA, Farzaneh F, Kitchener HC (2006) Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24(16):3087–3094. doi:10.1016/j.vaccine.2006.01.048

    Article  PubMed  Google Scholar 

  24. Crosignani P, De Stefani A, Fara GM, Isidori AM, Lenzi A, Liverani CA, Lombardi A, Mennini FS, Palu G, Pecorelli S, Peracino AP, Signorelli C, Zuccotti GV (2013) Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health. doi:10.1186/1471-2458-13-642

    PubMed Central  PubMed  Google Scholar 

  25. Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M (2013) Inequalities in the uptake of Human Papillomavirus Vaccination: a systematic review and meta-analysis. Int J Epidemiol. doi:10.1093/ije/dyt049

    Google Scholar 

  26. Constantine NA, Jerman P (2007) Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 40(2):108–115. doi:10.1016/j.jadohealth.2006.10.007

    Article  PubMed  Google Scholar 

  27. Davis K, Dickman ED, Ferris D, Dias JK (2004) Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 8(3):188–194

    Article  PubMed  Google Scholar 

  28. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE (2005) Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 159(2):132–137. doi:10.1001/archpedi.159.2.132

    Article  PubMed  Google Scholar 

  29. Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA (2008) Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 43(3):239–245. doi:10.1016/j.jadohealth.2008.06.009

    Article  PubMed  Google Scholar 

  30. Liddon NC, Hood JE, Leichliter JS (2012) Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006–2008 National Survey of Family Growth. Vaccine 30(16):2676–2682. doi:10.1016/j.vaccine.2012.02.007

    Article  PubMed  Google Scholar 

  31. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC (2006) Are women ready for the HPV vaccine? Gynecol Oncol 103(1):151–154. doi:10.1016/j.ygyno.2006.02.003

    Article  PubMed  Google Scholar 

  32. Polonijo AN, Carpiano RM (2013) Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory. Soc Sci Med 82:115–125. doi:10.1016/j.socscimed.2012.12.020

    Article  PubMed  Google Scholar 

  33. Chatzistamatiou K, Katsamagkas T, Zafrakas M, Zachou K, Orologa A, Fitsiou F, Theodoridis T, Konstantinidis T, Konstantinidis T, Agorastos T (2013) Smoking and genital human papilloma virus infection in women attending cervical cancer screening in Greece. World J Obstet Gynecol 2(3):53–61. doi:10.5317/wjog.v2.i3.53

    Article  Google Scholar 

  34. Kwan TTC, Chan KKL, Yip AMW, Tam KF, Cheung ANY, Lo SST, Lee PWH, Ngan HYS (2009) Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications. BJOG 116(4):501–510. doi:10.1111/j.1471-0528.2008.01988.x

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors cordially thank all medical, paramedical and technical personnel who voluntarily contributed to the realization of this study. The study was under the auspice of the Hellenic Ministry of Health and Social Solidarity (GMN DYG5/au 93880/08.09.2005), the Hellenic Ministry of Makedonia and Thrace (MN 5912/22.07.05), the Rectorat of the Aristotle University Thessaloniki (MN 49214/22.06.2005), the Prefecture of Thessaloniki (MN GN 2327/22.06.2005), the Hellenic Cancer Society MN 819/21.06.2005), and local authorities.

Conflict of interest

The study was financially supported by the Hellenic Ministry of Makedonia and Thrace (MN 5912/22.07.05), the Rectorat of the Aristotle University Thessaloniki (MN 30909/01.02.2006), the Bodossakis Foundation (MN 688/488/ek/30.11.2005), the Papageorgiou Foundation (MN 46/05.07.2005), Vianex SA Hellas, and local Authorities. All the authors report no other conflict of interest.

Author information

Author notes

  1. Κimon Chatzistamatiou

    Present address: , Mousson 9, 55236, Thessaloniki, Greece

Authors and Affiliations

  1. 4th Department of Obstetrics and Gynecology, Hippokrateio General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos, 49, 54642, Thessaloniki, Greece

    Theodoros Agorastos, Κimon Chatzistamatiou, Vagia Siamanta & Taxiarchis Katsamagkas

  2. School of Health and Medical Care, Alexander Technological Educational Institute of Thessaloniki, Thessaloniki, Greece

    Μenelaos Zafrakas

  3. Laboratory of Hygiene, Medical School, Democritus University of Thrace, Alexandroupolis, Greece

    Theodoros Constantinidis

  4. 1st Department of Obstetrics and Gynecology, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Αlexandros Lampropoulos

Authors
  1. Theodoros Agorastos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Κimon Chatzistamatiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Μenelaos Zafrakas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vagia Siamanta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Taxiarchis Katsamagkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Theodoros Constantinidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Αlexandros Lampropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

The LYSISTRATA study group

Corresponding author

Correspondence to Κimon Chatzistamatiou.

Additional information

Members of the LYSISTRATA study group is listed in Appendix.

Appendix

Appendix

The LYSISTRATA study group (in alphabetical order): Agorastos T, Athanatos D, Bili H, Chatzigeorgiou K, Chatzistamatiou Κ, Constantinidis T, Daglis T, Dampala K, Goulis D, Kalogiannidis I, Karagouni D, Katsamagkas T, Kitsou A, Kyrou D, Lampropoulos A, Mikos T, Nasioutziki M, Papasozomenou P, Salonikidou H, Siamanta V, Sotiriadis A, Tantsis A, Togaridou E, Tsertanidou A, Tympanidis I, Vavilis D, Zafrakas Μ.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agorastos, T., Chatzistamatiou, Κ., Zafrakas, Μ. et al. Distinct demographic factors influence the acceptance of vaccination against HPV. Arch Gynecol Obstet 292, 197–205 (2015). https://doi.org/10.1007/s00404-015-3614-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-015-3614-4

Keywords

Search

Navigation